Author:
Tian Shifeng,Xu Xiaoyi,Yang Xiaohui,Fan Linlin,Jiao Yuqi,Zheng Minying,Zhang Shiwu
Abstract
Follistatin-like protein 3 (FSTL3) is a type of FSTLs. By interacting with a disintegrin and metalloproteinase 12 (ADAM12), transforming growth factor-β ligands (activin, myostatin and growth differentiation factor (GDF) 11), FSTL3 can either activate or inhibit these molecules in human non-tumor pathophysiologies and cancers. The FSTL3 gene was initially discovered in patients with in B-cell chronic lymphocytic leukemia, and subsequent studies have shown that the FSTL3 protein is associated with reproductive development, insulin resistance, and hematopoiesis. FSTL3 reportedly contributes to the development and progression of many cancers by promoting tumor metastasis, facilitating angiogenesis, and inducing stem cell differentiation. This review summarizes the current pathophysiological roles of FSTL3, which may be a putative prognostic biomarker for various diseases and serve as a potential therapeutic target.
Funder
National Natural Science Foundation of China
Subject
Cell Biology,Developmental Biology
Reference105 articles.
1. Non-coding RNA networks in cancer;Anastasiadou;Nat. Rev. Cancer,2018
2. Myostatin regulates glucose uptake in BeWo cells;Antony;Am. J. Physiol. Endocrinol. Metab.,2007
3. MicroRNAs: Genomics, biogenesis, mechanism, and function;Bartel;Cell.,2004
4. FLRG, a new ADAM12-associated protein, modulates osteoclast differentiation;Bartholin;Biol. Cell.,2005
5. Identification of NF-kappaB responsive elements in follistatin related gene (FLRG) promoter;Bartholin;Gene,2007
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献